Epsilen Bio Company

Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases.
Technology: Immunotherapy
Industry: PharmTech
Headquarters: Milan, Lombardia, Italy
Founded Date: 2019
Employees Number: 1-10
Funding Status: Seed
Investors Number: 1
Last Funding Type: Seed

Visit Website
info@epsilenbio.com
Register and Claim Ownership